Position in ASND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$21,729,350
+$405,350 QoQ
Shares Held
95,000
-5.0% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
1.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Derivatives in ASND
reported options exposure · as of Mar 31, 2020CallValue
$39,413,500
CallShares
350,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cormorant Asset Management, LP holds $1,914,987,088 across 43 Biotechnology names. ASND ranks #25 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
885,500 | $285,299,245 | |
| 2 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
17,878,594 | $160,013,416 | |
| 3 | EYPT |
EyePoint, Inc.
|
8,265,000 | $106,535,850 | |
| 4 | EWTX |
Edgewise Therapeutics, Inc.
|
3,260,000 | $102,690,000 | |
| 5 | ERAS |
Erasca, Inc.
|
5,800,000 | $93,844,000 | |
| 6 | RAPP |
Rapport Therapeutics, Inc.
|
2,957,521 | $92,540,832 | |
| 7 | ALMS |
Alumis Inc.
|
3,949,241 | $87,001,779 | |
| 8 | ABVX |
Abivax S.A.
|
760,000 | $84,626,000 |
All Filings in ASND
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,729,350 | 95,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $21,324,000 | 100,000 | Shares | Defined | 2026-02-17 | |
| 2022-12-31 | $6,106,500 | 50,000 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,163,000 | 50,000 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,648,000 | 50,000 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,868,000 | 50,000 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,726,500 | 50,000 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $27,096,300 | 170,000 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,866,250 | 75,000 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $12,888,000 | 100,000 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $16,678,000 | 100,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $19,290,000 | 125,000 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $25,882,500 | 175,000 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $39,413,500 | 350,000 | Call | Defined | 2020-05-15 | |
| 2020-03-31 | $28,152,500 | 250,000 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||